Genetic renal problems Flashcards
syndrome of AME?
syndrome of apparent mineralocorticoid excess
- mutation of 11 BSD, which converts cortisol to cortisone.
- important in renal cells since cortisol activates mineralicorticoid receptor (with aldosterone), while cortisone doesn’t
- so, looks like primary aldosteronism
how to diagnose syndrome of apparent mineralocorticoid access (AME)?
-inheritance pattern?
-measure blood cortisol/cortisone ratio.
cortisone will be low/undetectable.
-also, gene sequencing, Auto rec.
Liddle syndrome
-mech
- “pseudoaldosteronism”
- mutation in ENaC channels, so they are constitutively active. (as if there is lots of aldosterone).
1. Na enters principal cells, so tubule lumen is negative
2. negative charge draws K+ from the principal cells. H+ follows the electronegativity as well, from the alpha intercalated cells.
gain of function mutation
AME syndrome vs Liddle syndrome:
-how are tx similar and different? why?
AME: can use ENaC blockers or Aldo blockers.
Liddle syndrome: can only use ENaC blockers b/c Aldo blockers don’t affect the constitutive activation of ENaC
ENaC blockers vs Aldo blockers:
list them
ENaC: amiloride, triamterene
Aldo: spironolactone, eplerenone
Gitelman and Bartter syndromes: what are they?
Bartter: mutation in Na/K/2 Cl transporter in loop of henle. (mimic loop diuretics)
Gitelman: mutation in Na/Cl transporter in DCT (mimic thiazides)
mnemonic to remember genetic renal tubular defects
kidneys put out FABulous Glittering Liquid
Fanconi–PCT
Bartter–Loop of henle, loops
Gitelman–DCT, thiazides
Liddle–ENaC
also: syndrome of AME–cortisol to cortisone (11 BHSD loss)
Fanconi syndrome
PCT defect. no specific channel–lots of things are not reabsorbed. (aa, glucose, HCO3, PO4, etc)